Table 2.
Blood transfusion therapy in each study period (2001-3 and 2005-7).
| Study period 2001-3 |
Study period 2005-7 |
P-value1 | ||
|---|---|---|---|---|
| Time to first blood product | min | 85 (33-151) | 26 (2-72) | < 0.001 |
| RBC 0-6 h | n | 4 (2-10) | 5 (2-12) | 0.280 |
| RBC total | n | 5 (2-10) | 5 (3-12) | 0.355 |
| FFP 0-6 h | n | 0 (0-4) | 3 (0-10) | < 0.001 |
| FFP total | n | 0 (0-4) | 3 (0-10) | < 0.001 |
| PLT 0-6 h | n | 0 (0-0) | 1 (0-4) | < 0.001 |
| PLT total | n | 0 (0-0) | 1 (0-4) | < 0.001 |
| FFP:RBC 0-6 h | ratio2 | 0 (0-0.33) | 0.56 (0-0.83) | < 0.001 |
| FFP:RBC total | ratio2 | 0 (0-0.36) | 0.60 (0-0.83) | < 0.001 |
| PLT:RBC 0-6 h | ratio2 | 0 (0-0) | 0.17 (0-0.33) | < 0.001 |
| PLT:RBC total | ratio2 | 0 (0-0) | 0.17 (0-0.33) | < 0.001 |
| PLT:FFP 0-6 h | ratio2 | 0 (0-0.09) | 0.40 (0.21-0.43) | < 0.001 |
| PLT:FFP total | ratio2 | 0 (0-0.14) | 0.40 (0.2-0.47) | < 0.001 |
1Patients from '2001-3 and 2005-7 were compared by Wilcoxon Rank Sum test. Data are presented as medians (IQR), with p-values in bold for variables with p < 0.05. 2A ratio of 0.56, 0.60, 0.17 and 0.40 corresponds to 1.8, 1.7, 5.9 and 2.5, respectively, RBC per FFP or PLT.